Korean Market
OWNR
REMED
★★

REMED's largest shareholder Geunyong Lee and related parties report change in stock collateral loans… 19.76% of total shares pledged, posing forced selling risk if stock price drops

 
MATR
REMED
★★

Decision to Enter into a 2 Billion Won Treasury Stock Acquisition Trust Contract (Shareholder Value Enhancement)

 
OTHR
REMED
★

Termination of 2 Billion Won Treasury Share Acquisition Trust Agreement

 
MATR
REMED
★

Termination of Trust Agreement Upon Completion of 632,137 Treasury Shares Acquisition

 
OWNR
REMED
★

Submission of Large Holdings Report Form

 
PERI
REMED
★★

Remed: Q1 2026 Revenue +11.6%, Net Profit +40.7%; Share Buyback and Cancellation Boost

 
OTHR
REMED
★★★

Remed uses 99.89% of KRW 2 billion share buyback trust contract

 
OWNR
REMED
★

Large Shareholding Report Form Only, No Substantive Information